We next investigated if loss of IGFBP-1 influences vascular function, recognizing that several studies report a negative correlation between IGFBP-1 and biomarkers of cardiovascular disease such as blood pressure, BMI, waist/hip ratio, and fasting insulin levels [6–8]. Here, IGFBP1 is linked to cardiovascular disorder.